Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
TP
Nothing will impact the share price except steps to a further trial and a JV
None of those can happen without all the work Synairgen have done over the last 23 months.
But again I ask if you k ow of something they should have done 20 months ago or 10 months ago then please do share and we can all decide whether your ideas hold merit?
Utter nonsense and not the first time you’ve peddled this TP
“The company have been working on a way forward, with no tangible success to date, for twenty three months!”
The company needed a deep dive of Sprinter to understand what went wrong and without those steps there would be no future success.
The company presented those findings in multiple global conferences which was absolutely necessary to promote the company’s future prospects.
The company produced podcasts, worked with ITN and with the former head of Barda in publicising their work.
They did a deep dive of the COPD trial and published and presented those results.
They’ve identified a need for patient targeting from all of this work and spent a year working with Southampton and Janssen on patient data to enable a further set of trials.
They’ve identified a need for a new test kit to use with patients and clearly been working with Casanova on adding that kit into their trials.
All of these things were and are critical to the success we all want and there are no shortcuts. I’m sure in the background there will have been many conversations with our biggest investors, BP about how we get to a P3
But as ever if you or anyone else has some great knowledge of what steps the company should have been carrying out and didn’t then please do share them but stop all of this 23 months nonsense because developing drugs is neither quick or easy!!
If someone has an example of a biotech issuing statements giving the detailed minutiae of the steps which have been completed in delivery of a forthcoming trial then please do share.
It’s worth bearing in mind that these same posters were asking for updates 2 months before the trial delivery window even opened.
I anticipate we will get a clinical program update nearer to the trial starting which is what most companies do.
As the window is H1 not Q1 I am not expecting that for several more weeks and that’s absolutely fine. I do not need to know the minutiae of the steps leading up to that date.
We are only 30 days into a 6 month window for delivery of the trials.
There is no absence of news, just a repetitive theme by certain posters trying to suggest a lack of news.
When you examine what new information might be available after 30 days into the window it’s clearly unrealistic expectation.
Nice to see this appearing in SM searches for Synairgen. It’s not new in content but appears to be a new link under this website.
https://www.medicalstartups.org/startup/synairgen/
Professional
Posted in: SNG
5 Jul 2023 16:07
Meltonboy already told you....will go when no more profits to be made....
If somebody would ve interested in this briljant science Company that would be bad for my short...
Will not worry about that scenario... haha
Tommy D. How can you conclude this is a “fake” account (whatever that means) and that I am a shorter”
Sakura7- science tells us that If it looks like a Duck, Swims like a duck and Quacks like a duck.
It’s probably a duck!
Professional. You’re here to rubbish the company …Thats your trading strategy
Professional
Posted in: SNG
RE: RM
5 Jul 2023 16:07
Meltonboy already told you....will go when no more profits to be made....
If somebody would ve interested in this briljant science Company that would be bad for my short...
Will not worry about that scenario... haha
I’m just here to chat about the share andwhen people spout out terms like “connective tissue “
Ask them what the F they mean. Sadly they can never explain it and when you dig deeper you realise they’re talking crap.
Always fun picking your points apart Doc
Lol
What was it you told us
You make 5% -7% on every trade
You can raise 5m for the board
Your serious question is what is another minor pi’s investment position on this share?
Tell me why would you be interested. I’d have thought you’d be more interested in asking a question of the board at the AGM but apparently not
No hypocrisy Mani
Just the difference between an irrational cry for regular updates when there’s nothing to update and a rational question within a reasonable timeframe knowing the deliverable window we’ve been told about. I don’t expect you to understand the difference
Fwiw
I would like to see a clinical program update by Q2 that tells us where we are in the regulatory approval process and I’ve emailed the company asking for one.
I think that’s a reasonable expectation given the H1 window